On November 11 and 12, FDA finally held a public hearing on how pharmaceutical, biotech, and medical companies can use the web and other social media to promote regulated products. For years companies have had little to no information about how far the FDA will allow them to go in media such as Google ads, Twitter, Facebook, and even their own websites.
So what really happened? What concerned industry most? Did FDA give away any of their plans? Registration closed quickly…and many who wanted to attend were turned away. Even those who were able attend will want to hear other expert interpretations of the discussions. On Thursday, November 19, beginning at 1:00 p.m., join FOI Services, Inc., Attorney Arnie Friede, and RTCRM’s Healthcare social media expert Carlen Lea lesser for a 90-minute teleconference.
You’ll hear expert analysis of what was surprising, what was left out, and what the major issues are going to be in the months and years to come.
To register online, or for details on additional upcoming teleconferences, go to www.foiservices.com/tc. You may also call 1-800-654-1147 (outside the US and Canada call +1-301-975-9400) to register by phone.
Comments are closed.